Feraheme

Type: Product
Name: Feraheme
First reported 21 hours ago - Updated 15 hours ago - 3 reports

AMAG Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results

(GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the first quarter ended March 31, 2014. The company achieved 17% total net revenue growth in ... [Published BioSpace - 15 hours ago]
First reported Apr 21 2014 - Updated Apr 21 2014 - 2 reports

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Long-Term Investor Alert: Investigation Announced

An investigation for current long-term investors in shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is ongoing and NASDAQ:AMAG stockholders should contact the Shareholders Foundation.San Diego, CA -- (SBWIRE) -- 04/21/2014 -- An investigation on behalf ... [Published Digital Journal - Apr 21 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Broadfin Capital Initiates New Positions In Corium International Inc (CORI), AMAG Pharmaceuticals Inc. (AMAG) and La Jolla Pharmaceutical Company (LJPC)

In three recent filings,   Kevin Kotler’s Broadfin Capital has revealed adding three companies:  Corium International Inc (NASDAQ : CORI ) , AMAG Pharmaceuticals Inc. (NASDAQ : AMAG ) and La Jolla Pharmaceutical Company (NASDAQ : LJPC )  to its equity ... [Published InsiderMonkey.com - Apr 17 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Attention Investors who purchased NASDAQ:AMAG shares: Investigation announced

The Shareholders Foundation announces that the investigation on behalf of current long-term investors in shares of AMAG Pharmaceuticals , Inc. (NASDAQ:AMAG) continues concerning potential breaches of fiduciary duties that caused damages to the company ... [Published Empowered News - Apr 14 2014]
First reported Apr 13 2014 - Updated Apr 13 2014 - 1 reports

OPKO HEALTH : Updates on Key Executive Appointments for Renal Division

Opko Health, Inc. announced the hiring of key executives for its Renal Division. Scott Toner will join as Vice President, US Marketing and Sales and Dr. Steve Strugnell will join as Senior Director, Scientific Affairs.According to a release, Toner has ... [Published 4 Traders - Apr 13 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

OPKO Health announces management changes

OPKO Health, Inc., a biopharmaceutical and diagnostics company, has appointed Scott Toner as vice president of US marketing and sales and Steve Strugnell as senior director of scientific affairs for the company's renal division. Mr Toner was previously ... [Published Individual.com - Apr 09 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 3 reports

Opko Health Reports Key Executive Appointments for Renal Division

(Close-Up Media via COMTEX News Network) -- Opko Health, Inc. announced the hiring of key executives for its Renal Division. Scott Toner will join as Vice President, US Marketing and Sales and Dr. Steve Strugnell will join as Senior Director, Scientific ... [Published PredictWallStreet - Apr 08 2014]
First reported Apr 03 2014 - Updated Apr 04 2014 - 1 reports

OPKO Health Announces Key Executive Appointments for Renal Division

MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE:OPK) today announced the hiring of key executives for its Renal Division. Scott Toner will join as Vice President, US Marketing and Sales and Dr. Steve Strugnell will join as Senior Director, Scientific ... [Published Investor's Business Daily - Apr 03 2014]
First reported Apr 01 2014 - Updated Apr 02 2014 - 1 reports

AMAG Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference

WALTHAM, Mass., (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. () today announced that William Heiden, AMAG's chief executive officer, will present at the 13 th Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 2:20 p.m. ET in New York. ... [Published OSIX News - Apr 01 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 2 reports

MERRIMACK PHARMACEUTICALS : to Present at the 2014 American Association for Cancer Research Annual Meeting

(GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that it will present at the 2014 AACR Annual Meeting. The conference will take place on April 5-9, 2014 at the San Diego Convention Center in San Diego . Presentations will ... [Published 4 Traders - Mar 31 2014]
First reported Feb 10 2014 - Updated Feb 10 2014 - 1 reports

AMAG Pharmaceuticals Announces Proposed Offering of $150 Million of Convertible Senior Notes due 2019

WALTHAM, Mass., Feb. 10, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that it intends to offer, subject to market and other conditions, $150 million aggregate principal amount of Convertible Senior Notes due 2019 (the ... [Published GlobeNewswire - Feb 10 2014]
First reported Feb 03 2014 - Updated Feb 04 2014 - 2 reports

AMAG Pharma's ferumoxytol gets new US patent

AMAG Pharmaceuticals, Inc. has received a key new US patent for ferumoxytol, Patent No. 8,591,864, Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents, expiring in March 2020 from Patent and Trademark Office (USPTO ... [Published PharmaBiz - Feb 04 2014]

Quotes

...In the oral mucositis market, MuGard® also generated accelerated growth," said William Heiden, president and chief executive officer. "In addition to operating the business effectively and with continued financial discipline this quarter, AMAG completed a $200 million convertible debt offering in February, which will enhance our ability to complete business development transactions to expand our product portfolio."
"Scott and Steve are powerful additions to our management team," said Dr. Charles W Bishop , CEO of Opko Renal. "These two individuals have a remarkable understanding of the renal market and provide unparalleled experience in developing and launching proprietary renal disease products."
...us to identify patients most likely to benefit from MM-398 treatment," said Jonathan Fitzgerald, Ph D , Senior Director of Discovery at Merrimack. "Though our initial data are from a small sample of a diverse patient population, we are encouraged to see that almost all of the tumor lesions that shrank after MM-398 treatment were associated with higher levels of ferumoxytol, as seen on the MRI."
Dr. Charles W Bishop, CEO of OPKO Renal. "These two individuals have a"

More Content

All (26) | News (24) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
AMAG Pharmaceuticals, Inc. Announces First Quar... [Published BioSpace - 15 hours ago]
AMAG Announces First Quarter 2014 Financial Res... [Published Virtual Strategy Magazine - 20 hours ago]
AMAG Announces First Quarter 2014 Financial Res... [Published GlobeNewswire - 21 hours ago]
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Long-T... [Published Digital Journal - Apr 21 2014]
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Long-T... [Published SBWire - Apr 21 2014]
Broadfin Capital Initiates New Positions In Cor... [Published InsiderMonkey.com - Apr 17 2014]
Attention Investors who purchased NASDAQ:AMAG s... [Published Empowered News - Apr 14 2014]
OPKO HEALTH : Updates on Key Executive Appointm... [Published 4 Traders - Apr 13 2014]
OPKO Health announces management changes [Published Individual.com - Apr 09 2014]
Merrimack Announces Preliminary Data From Pilot... [Published Benzinga.com - Apr 08 2014]
Opko Health Reports Key Executive Appointments ... [Published PredictWallStreet - Apr 08 2014]
OPKO HEALTH : Names Key Executive Appointments ... [Published 4 Traders - Apr 08 2014]
OPKO HEALTH : Reports Key Executive Appointment... [Published 4 Traders - Apr 08 2014]
OPKO Health Appoints Scott Toner and Steve Stru... [Published Citybizlist - Apr 04 2014]
OPKO Health Announces Key Executive Appointment... [Published Investor's Business Daily - Apr 03 2014]
OPKO Health : Announces Key Executive Appointme... [Published 4 Traders - Apr 03 2014]
AMAG Pharmaceuticals, Inc. to Present at the Ne... [Published OSIX News - Apr 01 2014]
MERRIMACK PHARMACEUTICALS : to Present at the 2... [Published 4 Traders - Mar 31 2014]
Merrimack to Present at the 2014 American Assoc... [Published Benzinga.com - Mar 31 2014]
AMAG Pharmaceuticals Announces Proposed Offerin... [Published GlobeNewswire - Feb 10 2014]
AMAG Pharma's ferumoxytol gets new US patent [Published PharmaBiz - Feb 04 2014]
AMAG Pharmaceuticals gets new US patent for fer... [Published Pharmaceutical Business Review - Feb 03 2014]
AMAG Pharmaceuticals Receives Complete Response... [Published GlobeNewswire: Acquisitions News - Jan 22 2014]
AMAG Pharmaceuticals, Inc. to Host Conference C... [Published GlobeNewswire: Acquisitions News - Jan 21 2014]
FDA extends AMAG Pharma review of sNDA for Fera... [Published Pharmaceutical Business Review - Oct 17 2013]
AMAG Pharma's ferumoxytol receives US patent [Published PharmaBiz - Aug 09 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
AMAG Pharmaceuticals Receives Complete Response... [Published GlobeNewswire: Acquisitions News - Jan 22 2014]
AMAG Pharmaceuticals, Inc. to Host Conference C... [Published GlobeNewswire: Acquisitions News - Jan 21 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.